A1C level and future risk of diabetes: a systematic review
- PMID: 20587727
- PMCID: PMC2890379
- DOI: 10.2337/dc09-1939
A1C level and future risk of diabetes: a systematic review
Abstract
We examined ranges of A1C useful for identifying persons at high risk for diabetes prior to preventive intervention by conducting a systematic review. From 16 included studies, we found that annualized diabetes incidence ranged from 0.1% at A1C <5.0% to 54.1% at A1C >or=6.1%. Findings from 7 studies that examined incident diabetes across a broad range of A1C categories showed 1) risk of incident diabetes increased steeply with A1C across the range of 5.0 to 6.5%; 2) the A1C range of 6.0 to 6.5% was associated with a highly increased risk of incident diabetes, 25 to 50% incidence over 5 years; 3) the A1C range of 5.5 to 6.0% was associated with a moderately increased relative risk, 9 to 25% incidence over 5 years; and 4) the A1C range of 5.0 to 5.5% was associated with an increased incidence relative to those with A1C <5%, but the absolute incidence of diabetes was less than 9% over 5 years. Our systematic review demonstrated that A1C values between 5.5 and 6.5% were associated with a substantially increased risk for developing diabetes.
Figures
Comment in
-
Comment on: Zhang et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010;33:1665-1673.Diabetes Care. 2011 Feb;34(2):e20; author reply e21. doi: 10.2337/dc10-1901. Diabetes Care. 2011. PMID: 21270178 Free PMC article. No abstract available.
References
-
- Forrest RD, Jackson CA, Yudkin JS: The glycohaemoglobin assay as a screening test for diabetes mellitus: the Islington Diabetes Survey. Diabet Med 1987; 4: 254–259 - PubMed
-
- Little RR, England JD, Wiedmeyer HM, McKenzie EM, Pettitt DJ, Knowler WC, Goldstein DE: Relationship of glycosylated hemoglobin to oral glucose tolerance: implications for diabetes screening. Diabetes 1988; 37: 60–64 - PubMed
-
- Modan M, Halkin H, Karasik A, Lusky A: Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol 1984; 119: 431–444 - PubMed